Tiger Vapor, LLC manufactured and distributed e-liquid tobacco products without obtaining required premarket authorization from the FDA, in violation of the Family Smoking Prevention and Tobacco Control Act. The company's e-liquid products, which contain nicotine and are classified as newly deemed tobacco products under FDA jurisdiction as of August 8, 2016, failed to comply with FD&C Act requirements mandating premarket approval for any tobacco products not commercially marketed before February 15, 2007. The Center for Tobacco Products determined that Tiger Vapor was distributing these unapproved tobacco products for commercial sale in the United States without the necessary marketing authorization order required under section 910 of the FD&C Act.